A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
Silvia Pietrobono, MD,
Davide Melisi, MD, PhD
Affiliations
Silvia Pietrobono, MD
Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy
Davide Melisi, MD, PhD
Correspondence Address correspondence to: Davide Melisi, MD, PhD, Digestive Molecular Clinical Oncology Unit, Section of Medical Oncology, Department of Medicine, University of Verona, AOUI Verona–Policlinico “G.B. Rossi,” Piazzale L.A. Scuro, 10, 37134, Verona, Italy.; Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Experimental Cancer Medicine Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy